Dxc facial en hombres
Facial Dermatitis in Men Referred for Patch Testing
TAKE-HOME MESSAGE
- In this retrospective analysis of 15,064 men who underwent patch testing, the proportion of those who presented with facial dermatitis increased from 5.6% between 1994 and 1996 to 10.6% between 2015 and 2016. The most frequent allergens affecting men with facial dermatitis were those found in personal care products, such as methylisothiazolinone, fragrance mix I, and balsam of Peru. Additionally, those with facial dermatitis were significantly more likely to react to dimethylaminopropylamine and paraphenylenediamine.
- As male grooming practices have changed over the years, there has been an increase in men presenting with facial dermatitis related to allergens in personal care products. It is important that clinicians are aware of this trend to recognize cases and administer patch testing in a timely manner.
– Caroline K. Crabtree, MD
IMPORTANCE
Facial dermatitis in women is well characterized. However, recent shifts in the men's grooming industry may have important implications for male facial dermatitis.
OBJECTIVE
To characterize male patients with facial dermatitis.
DESIGN, SETTING, AND PARTICIPANTS
A 22-year retrospective cross-sectional analysis (1994-2016) of North American Contact Dermatitis Group (NACDG) data, including 50 507 patients who underwent patch testing by a group of dermatology board-certified patch test experts at multiple centers was carried out. Facial dermatitis was defined as involvement of the eyes, eyelids, lips, nose, or face (not otherwise specified).
MAIN OUTCOMES AND MEASURES
The main outcome was to compare characteristics (including demographics and allergens) between male patients with facial dermatitis (MFD) and those without facial dermatitis (MNoFD) using statistical analysis (relative risk, CIs). Secondary outcomes included sources of allergic and irritant contact dermatitis and, for occupationally related cases, specific occupations and industries in MFD.
RESULTS
Overall, 1332 male patients (8.0%) were included in the MFD group and 13 732 male patients (82.0%) were included in MNoFD. The mean (SD) age of participants was 47 (17.2) years in the MFD group and 50 (17.6) years in the MNoFD group. The most common facial sites were face (not otherwise specified, 817 [48.9%]), eyelids (392 [23.5%]), and lips (210 [12.6%]). Participants in the MFD group were significantly younger than MNoFD (mean age, 47 vs 50 years; P < .001). Those in the MFD group were less likely to be white (relative risk [RR], 0.92; 95% CI, -0.90 to 0.95) or have occupationally related skin disease (RR, 0.49; 95% CI, -0.42 to 0.58; P < .001) than MNoFD. The most common allergens that were associated with clinically relevant reactions among MFD included methylisothiazolinone (n = 113; 9.9%), fragrance mix I (n = 27; 8.5%), and balsam of Peru (n = 90; 6.8%). Compared with MNoFD, MFD were more likely to react to use of dimethylaminopropylamine (RR, 2.49; 95% CI, -1.42 to 4.37]) and paraphenylenediamine (RR, 1.43; 95% CI, -1.00 to 2.04; P < .001). Overall, 60.5% of NACDG allergen sources were personal care products.
CONCLUSIONS AND RELEVANCE
Although many allergens were similar in both groups, MFD were more likely to react to use of dimethylaminopropylamine and paraphenylenediamine, presumably owing to their higher prevalence in hair products. Most sources of allergic and irritant contact dermatitis in MFD were personal care products. This study provides insight into the risks and exposures of the increasing number of grooming products used by male dermatology patients. This will enable clinicians to better identify male patients who would benefit from patch testing and treat those with facial dermatitis.
JAMA Dermatology
Facial Dermatitis in Male Patients Referred for Patch Testing: Retrospective Analysis of North American Contact Dermatitis Group Data, 1994 to 2016
JAMA Dermatol 2019 Nov 27;[EPub Ahead of Print], EM Warshaw, JP Schlarbaum, HI Maibach, JI Silverberg, JS Taylor, AR Atwater, MJ Reeder, JG DeKoven, MD Pratt, VA DeLeo, KA Zug, AF Fransway, DV Belsito, T Mathias, JF Fowler, JG Marks, D Sasseville, MJ Zirwas
Skin Care Physicians of Costa Rica
Clinica Victoria en San Pedro: 4000-1054
Momentum Escazu: 2101-9574
Please excuse the shortness of this message, as it has been sent from
a mobile device.
posted by dermatica at
December 13, 2019
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home